Cardiovascular research is a primary focus area for Novella’s MedTech division, accounting for more than half of our device delivery portfolio. Cardiovascular disease is the leading cause of death worldwide, and the demand for effective prevention and treatment remains strong.*
Novella provides access to world-class cardiologists and cardiac surgeons, and fosters working relationships with leading cardiac research centers including our collaboration with the Cardiovascular Research Foundation Clinical Trials Center, an academic research organization. Through these relationships, Novella provides our customers access to advanced cardiovascular core labs and imaging vendors.
We continue to earn preferred provider status with several of the world’s premier medical device companies. These relationships range in size from small to large manufacturers across multiple modalities in the interventional cardiac and vascular arena which allow us to fully support clinical studies across North America, EMEA and Asia Pacific.
Novella’s MedTech staff studies a global training curriculum specific to medical device clinical research which includes safety reporting, design validation, health economics and core therapeutic training across the coronary and/or cardiovascular disease state relevant to their study assignment.
Contact us to learn how Novella can advance your cardiovascular device program.
* World Health Organization. Cardiovascular Diseases Fact Sheet, No. 317. January 2015.